tiprankstipranks
OncoArendi Therapeutics SA (PL:MOC)
:MOC
Poland Market
MOC
OncoArendi Therapeutics SA
RESEARCH TOOLSreports

OncoArendi Therapeutics SA (MOC) Ratios

0 Followers

OncoArendi Therapeutics SA Ratios

PL:MOC's free cash flow for Q4 2025 was zł0.00. For the 2025 fiscal year, PL:MOC's free cash flow was decreased by zł and operating cash flow was zł0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Mar 24Dec 22
Liquidity Ratios
Current Ratio
 4.79 4.79 9.82 10.87 10.74
Quick Ratio
 4.79 4.79 9.82 10.87 10.74
Cash Ratio
 4.54 4.54 3.55 10.59 9.40
Solvency Ratio
 -1.81 -1.81 -2.66 -2.25 -0.82
Operating Cash Flow Ratio
 -5.55 -5.40 -11.14 -3.85 -1.46
Short-Term Operating Cash Flow Coverage
 -9.86 -9.58 -26.12 -10.76 -4.63
Net Current Asset Value
zł 10.24Mzł 10.24Mzł 39.94Mzł 54.37Mzł 63.38M
Leverage Ratios
Debt-to-Assets Ratio
 0.06 0.06 0.06 0.06 0.05
Debt-to-Equity Ratio
 0.06 0.06 0.07 0.07 0.05
Debt-to-Capital Ratio
 0.06 0.06 0.07 0.07 0.05
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.08 1.08 1.10 1.11 1.09
Debt Service Coverage Ratio
 -9.05 -9.05 -12.02 -11.32 -13.56
Interest Coverage Ratio
 -245.92 -286.48 -356.66 -360.18 -2.68K
Debt to Market Cap
 0.02 0.02 0.01 <0.01 0.01
Interest Debt Per Share
 0.26 0.26 0.36 0.43 0.46
Net Debt to EBITDA
 0.58 0.58 0.40 2.23 1.86
Profitability Margins
Gross Profit Margin
66.49%0.00%-16.78%-4101610.00%-0.28%
EBIT Margin
-609.51%0.00%-1068.61%-28373116.00%-476.92%
EBITDA Margin
-633.05%0.00%-937.75%-25505806.00%-423.89%
Operating Profit Margin
-629.41%0.00%-1151.35%-32128045.00%-584.40%
Pretax Profit Margin
-522.02%0.00%-1071.83%-28373117.00%-478.49%
Net Profit Margin
-522.02%0.00%-1071.83%-28373117.00%-180.21%
Continuous Operations Profit Margin
-522.02%0.00%-1071.83%-28373117.00%-478.49%
Net Income Per EBT
100.00%100.00%100.00%100.00%37.66%
EBT Per EBIT
82.94%71.20%93.09%88.31%81.88%
Return on Assets (ROA)
-16.61%-16.61%-27.51%-25.27%-9.81%
Return on Equity (ROE)
-16.97%-17.94%-30.26%-28.11%-10.71%
Return on Capital Employed (ROCE)
-20.82%-24.26%-30.95%-30.24%-33.50%
Return on Invested Capital (ROIC)
-20.37%-23.73%-29.75%-29.06%-30.85%
Return on Tangible Assets
-65.71%-65.71%-52.37%-37.18%-15.63%
Earnings Yield
-14.70%-11.62%-15.33%-8.64%-6.77%
Efficiency Ratios
Receivables Turnover
 5.54 0.00 0.10 0.01 488.33
Payables Turnover
 1.13 0.00 1.86 1.36 0.58
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.45 0.00 0.31 <0.01 0.65
Asset Turnover
 0.03 0.00 0.03 <0.01 0.05
Working Capital Turnover Ratio
 0.18 0.00 0.06 <0.01 0.08
Cash Conversion Cycle
 -256.24 0.00 3.59K 34.91K -629.59
Days of Sales Outstanding
 65.88 0.00 3.79K 35.18K 0.75
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 322.12 0.00 195.81 268.45 630.34
Operating Cycle
 65.88 0.00 3.79K 35.18K 0.75
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.97 -0.95 -2.82 -1.38 -0.73
Free Cash Flow Per Share
 -1.15 -0.95 -4.00 -1.40 -3.13
CapEx Per Share
 0.18 <0.01 1.18 0.02 2.40
Free Cash Flow to Operating Cash Flow
 1.19 1.00 1.42 1.02 4.29
Dividend Paid and CapEx Coverage Ratio
 -5.34 -6.47M -2.40 -64.30 -0.30
Capital Expenditure Coverage Ratio
 -5.34 -6.47M -2.40 -64.30 -0.30
Operating Cash Flow Coverage Ratio
 -3.77 -3.67 -7.88 -3.26 -1.59
Operating Cash Flow to Sales Ratio
 -6.64 0.00 -19.52 -232.90K -1.36
Free Cash Flow Yield
-22.21%-14.38%-39.58%-7.20%-21.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -6.80 -8.61 -6.52 -11.57 -14.78
Price-to-Sales (P/S) Ratio
 35.51 0.00 69.90 3.28M 26.63
Price-to-Book (P/B) Ratio
 1.22 1.54 1.97 3.25 1.58
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.50 -6.95 -2.53 -13.88 -4.56
Price-to-Operating Cash Flow Ratio
 -5.35 -6.95 -3.58 -14.10 -19.59
Price-to-Earnings Growth (PEG) Ratio
 -0.19 0.17 0.79 0.34 -0.09
Price-to-Fair Value
 1.22 1.54 1.97 3.25 1.58
Enterprise Value Multiple
 -5.03 -6.52 -7.05 -10.64 -4.42
Enterprise Value
 95.67M 123.96M 193.10M 271.45M 140.86M
EV to EBITDA
 -5.03 -6.52 -7.05 -10.64 -4.42
EV to Sales
 31.83 0.00 66.15 2.71M 18.75
EV to Free Cash Flow
 -4.04 -6.39 -2.39 -11.48 -3.21
EV to Operating Cash Flow
 -4.79 -6.39 -3.39 -11.66 -13.79
Tangible Book Value Per Share
 0.82 0.83 2.45 3.86 5.35
Shareholders’ Equity Per Share
 4.24 4.27 5.12 5.99 9.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.05
Revenue Per Share
 0.15 0.00 0.14 <0.01 0.54
Net Income Per Share
 -0.76 -0.77 -1.55 -1.69 -0.97
Tax Burden
 1.00 1.00 1.00 1.00 0.38
Interest Burden
 0.86 0.71 1.00 1.00 1.00
Research & Development to Revenue
 0.33 0.00 0.81 27.19K 1.55
SG&A to Revenue
 4.33 0.00 9.27 0.00 0.80
Stock-Based Compensation to Revenue
 0.00 0.00 1.38 0.00 0.06
Income Quality
 1.27 1.24 1.82 0.82 0.67
Currency in PLN